Log in
Enquire now
ProterixBio

ProterixBio

ProterixBio is a Billerica, Massachusetts-based diagnostic tools company developing chronic respiratory disease diagnostics.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
Also Known As
BioScale
Marked BioChips
CEO
‌
Michael Miller
Legal Name
ProterixBio, Inc.
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...bioscale
Email Address
info@proterixbio.com
Founded Date
2002
Founder
‌
Mark Lundstrom
‌
Edward Crawley
Full Address
1 Fortune Drive, Billerica, MA 01821 USA
Industry
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Engineering
Engineering
Biomedical engineering
Biomedical engineering
Proteomics
Proteomics
Healthcare
Healthcare
Diagnostic tools
Diagnostic tools
Health Diagnostics
Health Diagnostics
‌
Diagnostic Equipment
Investors
‌
MF Capital
0
New Science Ventures
New Science Ventures
BlackFin Capital Partners
BlackFin Capital Partners
Latest Funding Round Date
July 9, 2013
Latest Funding Round Amount (USD)
18,800,000
LinkedIn URL
@company/proterixbioinc
Location
United States
United States
Billerica, Massachusetts
Billerica, Massachusetts
Number of Employees (Ranges)
11 – 50
Patents Assigned (Count)
1
Phone Number
+19789016700
Pitchbook URL
pitchbook.com/profiles.../43069-42
Total Funding Amount (USD)
28,950,082
Official Website
proterixbio.com

Find more companies like ProterixBio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.